Invesco Markets - Invesco NASDAQ Biotech UCITS ETF (SWX:SBIO) - Stock Price, News & Analysis

SBIO Stock Overview

Invesco Markets Plc - Invesco NASDAQ Biotech UCITS ETF is an exchange traded fund launched by Source Investment Management Limited.

About the company

SBIO fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Invesco Markets Plc - Invesco NASDAQ Biotech UCITS ETF Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Invesco Markets - Invesco NASDAQ Biotech UCITS ETF
Historical stock prices
Current Share Price	US$46.02
52 Week High	US$47.32
52 Week Low	US$37.71
Beta	0
1 Month Change	-1.44%
3 Month Change	0.41%
1 Year Change	8.65%
3 Year Change	-5.75%
5 Year Change	26.09%
Change since IPO	46.27%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	SBIO	CH Capital Markets	CH Market
7D	1.5%	-1.3%	0.8%
1Y	8.7%	37.2%	2.4%

Return vs Industry: SBIO underperformed the Swiss Capital Markets industry which returned 37.2% over the past year.

Return vs Market: SBIO exceeded the Swiss Market which returned 2.4% over the past year.

Price Volatility

Is SBIO's price volatile compared to industry and market?
SBIO volatility
SBIO Average Weekly Movement	2.1%
Capital Markets Industry Average Movement	3.2%
Market Average Movement	3.4%
10% most volatile stocks in CH Market	7.7%
10% least volatile stocks in CH Market	1.8%

Stable Share Price: SBIO has not had significant price volatility in the past 3 months.

Volatility Over Time: SBIO's weekly volatility (2%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2014	n/a	n/a	https://www.powersharesetf.com/gb/institutional/en/product/source-nasdaq-biotech-ucits-etf/trading-information

Invesco Markets Plc - Invesco NASDAQ Biotech UCITS ETF is an exchange traded fund launched by Source Investment Management Limited. The fund is managed by Assenagon Asset Management S.A. It invests in the public equity markets across the globe.

Invesco Markets Plc - Invesco NASDAQ Biotech UCITS ETF Fundamentals Summary

How do Invesco Markets - Invesco NASDAQ Biotech UCITS ETF's earnings and revenue compare to its market cap?
SBIO fundamental statistics
Market cap	n/a
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is SBIO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SBIO income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did SBIO perform over the long term?

See historical performance and comparison